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1 |  INTRODUCTION
Nonconvulsive status epilepticus (NCSE) is defined as a con-
tinuous state of seizures without convulsions or multiple non-
convulsive seizures for more than 30 minutes without interictal 
full recovery.1 It is a neurologic emergency with high morbidity 
and mortality.2 Clinical symptoms of NCSE can be subtle and 
misleading and therefore diagnosing NCSE relies heavily on 
electroencephalography (EEG). Different EEG criteria for NCSE 
exist (for a summary see reference 33) and a global or regional 
consensus is lacking. Diagnostic criteria with high sensitivity for 
NCSE would improve diagnostic accuracy and clinical manage-
ment, whereas global consensus on, and general application of 
these criteria would greatly benefit communication and research.
The Salzburg 2013 criteria for diagnosing NCSE4,5 were 
the first criteria to be clinically validated.6 In this clinical 
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Abstract
To improve the diagnostic accuracy of electroencephalography (EEG) criteria for 
nonconvulsive status epilepticus (NCSE), external validation of the recently pro-
posed Salzburg criteria is paramount. We performed an external, retrospective, diag-
nostic accuracy study of the Salzburg criteria, using EEG recordings from patients 
with and without a clinical suspicion of having NCSE. Of the 191 EEG recordings, 
12 (12%) was classified as an NCSE according to the reference standard. In the vali-
dation cohort, sensitivity was 67% and specificity was 89%. The positive predictive 
value was 47% and the negative predictive value was 95%. Ten patients in the control 
group (n = 93) were false positive, resulting in a specificity of 89.2%. The interrater 
agreement between the reference standards and between the scorers of the Salzburg 
criteria was moderate; disagreement occurred mainly in patients with an epileptic 
encephalopathy. The Salzburg criteria showed a lower diagnostic accuracy in our 
external validation study than in the original design, suggesting that they cannot re-
place the current practice of careful weighing of both clinical and EEG information 
on an individual basis.
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validation study, a very high sensitivity (97.7%, 95% con-
fidence interval [95% CI] 87.9‐99.6) and specificity (86%, 
80.8‐94.6,) were found with an overall accuracy of 92.5% 
(88.3‐97.5). The report represents a praiseworthy effort 
to improve EEG diagnostic consensus of NCSE. However, 
the study design has limitations that could hamper external 
implementation.7,8 One of the main concerns was the in-
volvement of many of the local study physicians who were 
attendants of the Salzburg 2013 meeting; inclusion of their 
bias while scoring the reference standard cannot be ruled out. 
In addition, 36% of included patients had an NCSE, which is 
a much higher percentage when compared to literature9 and 
our own clinical experience and therefore possibly a differ-
ent patient cohort or setting. These limitations could ham-
per external validation, which is considered a critical step in 
prognostic models.10 Here we report an independent clinical 
validation of the Salzburg criteria for the diagnosis of NCSE 
in two different tertiary healthcare settings.
2 |  METHODS
A retrospective, diagnostic accuracy study was conducted 
using acute video‐EEG recordings lasting 30‐60 minutes from 
patients admitted to the Radboud University Medical Center 
(Radboudumc), a university hospital with a large neurocritical 
care unit, and Kempenhaeghe, a national tertiary referral center 
for epilepsy and sleep disorders, both in The Netherlands. In 
our study, we followed the methods as described in the original 
Salzburg criteria paper by Leitinger et al.6
2.1 | Study design and participants
All consecutive EEG recordings from both adult and pedi-
atric patients with a clinical suspicion of NCSE (defined by 
the referral reason of the EEG being NCSE) were included in 
the clinically suspected NCSE group. All consecutive EEG 
recordings without a clinical suspicion but with an abnor-
mal EEG were included in the clinically not “suspected for 
NCSE” group. We excluded patients with technically insuf-
ficient EEG recordings (where interpretation was not pos-
sible due to artifacts) and EEG recordings lasting less than 
30 minutes. The diagnostic algorithm was validated in a con-
trol group consisting of EEG recording with any abnormal 
findings from patients without a clinically suspected NCSE. 
Based on the results from previous study, we calculated that 
100 patients in both groups would be needed to adequately 
power the study.
2.2 | Procedures
As a part of standard care, the university center used the 
Hirsh criteria,11 while no specific criteria were used in the 
tertiary epilepsy center. All EEG reviewers were board‐
certified clinical neurophysiologists with varying years 
of experience that reflects clinical practice. None of the 
authors were familiar with the Salzburg criteria prior to 
this study. Four authors (I.L. and M.Z. at Kempenhaeghe 
and N.A. and M.A. at the Radboudumc) thoroughly stud-
ied the clinical criteria as stated in the original article4 and 
retrospectively assessed the EEG recordings while being 
blinded to clinical data.
2.3 | Reference standard
As a reference standard, the expert opinion of another four 
authors was sought, who had access to all clinical informa-
tion (including laboratory tests, imaging studies, response to 
treatment, follow‐up, and outcome) and all EEG recordings, 
and were blinded to the Salzburg scorings. These reference 
authors (J.A. and C.A. at Kempenhaeghe and J.P. and C.S. 
at Radboudumc) individually reviewed the cases. If the in-
dividual conclusions differed, the cases were reevaluated by 
both clinicians together to reach a consensus. This consensus 
scoring was used in the comparisons.
2.4 | Statistics
Standard calculations for sensitivity, specificity, predictive 
values, and likelihood ratios were used.
Spearman correlations were calculated for interrater 
agreement. Data were stored in the data management system 
Castor12 and for analysis we used Prism 5 software (GraphPad 
Software Inc., San Diego, CA). A P‐value of < 0.05 was con-
sidered significant.
3 |  RESULTS
3.1 | Demographics
A total of 191 EEG studies from 187 patients were re-
viewed: 50 EEG recordings in the clinical validation group 
were obtained between May 28, 2015 and Oct 1, 2016 at the 
epilepsy centre Kempenhaeghe, and 47 in the clinical vali-
dation group were collected between Dec 1, 2015 and Nov 
22, 2016 at the Radboudumc. For the control groups, 50 con-
secutive EEG recordings between Apr 1 and Sep 30, 2016 
were collected at Kempenhaeghe and 44 were collected be-
tween Jan 4, 2016 and Nov 16, 2016 at the Radboudumc 
(Figure 1). In the clinical validation group (patients with a 
clinical suspicion of an NCSE), the patients were older, had 
more frequently prior cerebral hypoxia, and a decreased 
vigilance compared to the control group (patients without a 
clinical suspicion of an NCSE). In the patient group at the 
university hospital, 21% had a prior diagnosis of epilepsy 
and 15% had a history of cerebral hypoxia, whereas in the 
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patient group at the epilepsy center, 98% had a prior diag-
nosis of epilepsy and no patients had a history of cerebral 
hypoxia (see Table 1).
3.2 | Diagnostic accuracy of 
Salzburg criteria
Of the 97 patients with a clinically suspected NCSE, 12 were 
classified as being an NCSE by the reference standard, result-
ing in a pretest probability of NCSE of 11% at the university 
hospital and 16% at the epilepsy center. The Salzburg criteria in 
our cohort of patients with a possible NCSE had an overall sen-
sitivity of 67% and a specificity of 89%. The negative predictive 
value was 95% and the positive predictive value was 47%, with 
a positive likelihood ratio of 6.3 and a negative likelihood ratio 
of 0.4 (see Table 1). In the control group, 11 patients fulfilled 
the Salzburg criteria (specificity 89.2%), of which one was con-
firmed by the reference standard (true positive) and 10 were not 
confirmed (false positives). In these false‐positive EEG find-
ings, the criteria were fulfilled during a seizure with postictal 
recovery without a clinical suspicion of NCSE (Table S1).
3.3 | Interrater agreement
The interrater agreement between the reference standards 
was moderate (Spearman rs = 0.54; P < 0.001). The inter-
rater disagreements occurred mainly in patients with a severe 
epileptic encephalopathy vs an NCSE. The interrater agree-
ment between the scorers of the Salzburg criteria was also 
moderate (Spearman rs = 0.41; P < 0.001). The reasons for 
disagreement were the following: two patients with severe 
epileptic encephalopathy, one metabolic encephalopathy, 
and one patient with subtle signs of convulsive status epi-
lepticus (nystagmoid eye movements) vs NCSE. In 4 of 191 
patients, the consensus rating was different from both the two 
original ratings.
F I G U R E  1  Flowchart of the study
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4 |  DISCUSSION
In this external validation study, we found the Salzburg cri-
teria for diagnosing NCSE to have a moderate diagnostic 
accuracy and interrater consistency. We found a moderate 
sensitivity and a reasonable to good specificity. Therefore, 
the Salzburg criteria appear to be possibly useful as a primary 
screening method for NCSE with a high negative predictive 
value, but lack precision to objectively diagnose the condi-
tion in different clinical practice settings.
The diagnostic accuracy of the Salzburg criteria we found 
is clearly lower than in the original validation study.6 In the 
validation group, the lower positive predictive value of the 
Salzburg criteria can be largely explained by the markedly 
lower number of true positives (8/97 in the current study 
compared to 42/120 in the original article). Therefore, fol-
lowing Bayesian reasoning, because the a priori chance of 
having an NCSE is relatively low, as in our study and as 
found in literature,9 the positive predictive value and sensitiv-
ity of the Salzburg criteria decrease. Unsurprisingly, this will 
mean that the clinical value of the criteria will depend on the 
patient case mix and the a priori chance of having NCSE for 
any given center. The high number of false positives in both 
the validation (9/97) and in the control group (10/94) may 
lead to aggressive antiseizure therapy, which is unnecessary 
and probably deleterious for the patient.
We feel that the main reason for not being able to apply 
the Salzburg criteria successfully in all patients is that there 
are inherent pitfalls in applying the criteria to patients with an 
epileptic encephalopathy such as a hypsarrhythmia or multiple 
independent spike foci pattern (that may or may not be known 
prior to the EEG), in whom NCSE is suspected. These patients 
will have an overall abnormal background recording and usu-
ally will show epileptiform discharges for >10 seconds that are 
often in the 2‐5 cycles/seconds range with some fluctuation. 
That automatically puts these patients in the “possible NCSE” 
group, without the need for any additional abnormality that 
would positively indicate an additional NCSE in this group. 
We would therefore recommend to expand the criteria with an 
initial reading of the clinical info and EEG for the diagnosis 
of epileptic encephalopathy, and, if that is found, to further 
exclude these patients from applying the criteria as they are 
currently formulated. In addition, further defining the termi-
nology used, with more precise specification of terms such as 
discharges, fluctuation, and evolution, and adding a quantita-
tive method that can interpret the dynamics of the EEG, might 
also help to not overinterpret these patterns.
In addition, patients with diffuse encephalopathies who 
show generalized or lateralized periodic discharges, such 
as seen in postaxonic encephalopathy (PAE), will also au-
tomatically be classified in the “possible NCSE” group, 
even though that label is of questionable value in cases with 
PAE. It is still debatable whether to call a lateralized peri-
odic discharge an epileptic discharge,13 and qualifications 
such as “relatively uniform morphology” can also lead to 
subjective interpretation. Therefore, it may also be neces-
sary to exclude this particular pathology from further in-
terpretation using the Salzburg criteria, or further specify 
which dynamic patterns can be interpreted safely within 
that framework. Alternatively, one could consider giving 
a different weight to the “possible NCSE” classification, 
interpreting that subgroup as “not certain enough to initiate 
treatment,” instead of grouping it with “definite NCSE” as 
done in the original study.
T A B L E  1  Cross tables for both patients groups
Patients with clinically suspected NCSE NCSE reference No NCSE reference  
NCSE Salzburg; Total (E/A) 8 (4/4) 9 (2/7) 17 (PPV 
8/17 = 47.1%)
No NCSE Salzburg; Total (E/A) 4 (4/0) 76 (40/36) 80 (NPV 
76/80 = 95.0%)
  12 85 97
  Sens 8/12 = 66.7% Spec 76/85 = 89.4%  
Patients without clinically suspected 
NCSE NCSE reference No NCSE reference  
NCSE Salzburg; Total (E/A) 1 (0/1) 10 (1/9) 11 (PPV 
1/11 = 9.1%)
No NCSE Salzburg; Total (E/A) 0 83 (49/34) 83 (NPV 
83/83 = 100%)
  1 93 94
  Sens 1/1 = 100% Spec 83/93 = 89.2%  
Abbreviations: A, academic center; E, epilepsy center; NCSE, nonconvulsive status epilepticus; NPV, negative predictive value; PPV, positive predictive value; sens, 
sensitivity; spec; specificity.
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Other explanations for the lower diagnostic accuracy 
compared to the original article may be the variability in the 
reference standard scorings in our study, and the possibly 
different duration of the EEG recordings (30‐60 minutes in 
our study, a minimum of 20 minutes or more in the origi-
nal paper). In addition, at least some of the authors of the 
original article may have had a certain level of experience 
using the criteria, which could have affected their interrater 
variability, both in the study and reference group.7 The vari-
ability in reference standard scorings was high in our cohort, 
which is known from literature, for example, in hypsarrhyth-
mia patterns.14,15 This emphasizes how difficult and subjec-
tive EEG scoring, including that of an NCSE, currently is, 
and how useful it would be to have objective, straightfor-
ward criteria to help clinicians do that. We would also like to 
stress, as the original paper did, that the diagnosis of NCSE 
still begins with a clinical judgment about its likelihood, and 
that clinical data need to be incorporated in the final decision 
about NCSE or not.
The results of this study are limited by various factors 
similar to the original article, such as the absence of a true 
gold standard and the retrospective design of this study; spe-
cifically because the clinical decision to give antiepileptic 
drugs is a step in the Salzburg criteria that cannot be taken 
retrospectively. Future validation studies should therefore 
preferentially be executed prospectively in a real‐time patient 
care setting.
We conclude that diagnosing NCSE is difficult, and this 
problem is not yet solved by the Salzburg criteria. The criteria 
showed a lower diagnostic accuracy in our external validation 
study than in the original design, suggesting that they cannot 
be automatically transferred to any clinical setting where an 
EEG interpretation for suspected NCSE is needed. The main 
confounders for correct interpretation were patients with an 
epileptic encephalopathy or an encephalopathy with periodic 
discharges. If the Salzburg criteria are to be implemented in 
everyday practice, we suggest adapting the decision rules and 
interpretation to avoid overinterpreting the EEG results and 
improve specificity.
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